| 前列腺素E1联合低分子右旋糖酐治疗肝硬化难治性腹水 |
| |
| 引用本文： | 殷卫卫. 前列腺素E1联合低分子右旋糖酐治疗肝硬化难治性腹水[J]. 中国基层医药, 2005, 12(2): 150-150 |
| |
| 作者姓名： | 殷卫卫 |
| |
| 作者单位： | 210003,江苏,南京,南京市第二医院一病区 |
| |
| 摘 要： | 目的观察前列腺素E1联合低分子右旋糖酐治疗肝硬化难治性腹水疗效.方法肝硬化难治性腹水患者64例随机平均分为两组.对照组常规护肝、利尿、补充白蛋白和血浆;治疗组除白蛋白外在对照组的基础上加用前列腺素E1和低分子右旋糖酐.结果治疗组腹水得到很好的消退,与对照组相比差异有显著意义(P＜0.05).结论前列腺素E1和低分子右旋糖酐可起到扩充血容量、提高血浆胶体渗透压、改善微循环、使肾血流量增加和促进利尿排钠的作用,可使肝硬化难治性腹水得到很好的消退.
|
| 关 键 词： | 难治性腹水 低分子右旋糖酐 治疗 前列腺素E1 肝硬化 对照组 联合 结论 补充 目的 |
| 修稿时间： | 2004-11-12 |
Clinical study on the treatment of hard hepatocirrhosis ascites by prostaglandin E1 and low molecular dextran 40 |
| |
| YIN Wei-wei. Clinical study on the treatment of hard hepatocirrhosis ascites by prostaglandin E1 and low molecular dextran 40[J]. Chinese Journal of Primary Medicine and Pharmacy, 2005, 12(2): 150-150 |
| |
| Authors: | YIN Wei-wei |
| |
| Abstract: | Objective Study the joint curative effect of prostaglandin E_1 and DEXTRAN 40 on hard hepatocirrhosis ascites.Methods Divided 64 patients with hard hepatocirrhosis ascites into two groups randomly.The control group:received regular live protection,diuresis,and supplementation of albumin and plasma.Study group:used prostaglandin E_1 and DEXTRAN 40 apart from albumin.Result The ascites subsided significantly,the difference between the study group and control group is quite obvious(P<0.05).Conclusion Prostaglandin E_1 and DEXTRAN 40 can increase the amount of blood in the blood vessel,increase the infiltrating pressure of the plasma colloid,ameliorate the micro circulation,increase the blood flow in the kidney,and improve diuresis,so as to reduce the ascites. |
| |
| Keywords: | Prostaglandin E_1 Low molecular dextran Cirrhosis of liver Ascites |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
